Testing the significance of assuming homogeneity in
  contingency-tables/cross-tabulations by Tygert, Mark
ar
X
iv
:1
20
1.
14
21
v1
  [
sta
t.M
E]
  6
 Ja
n 2
01
2
Testing the significance of assuming homogeneity in
contingency-tables/cross-tabulations
Mark Tygert
May 2, 2018
Abstract
The model for homogeneity of proportions in a two-way contingency-table/cross-
tabulation is the same as the model of independence, except that the probabilistic
process generating the data is viewed as fixing the column totals (but not the row
totals). When gauging the consistency of observed data with the assumption of inde-
pendence, recent work has illustrated that the Euclidean/Frobenius/Hilbert-Schmidt
distance is often far more statistically powerful than the classical statistics such as χ2,
the log–likelihood-ratio G2, the Freeman-Tukey/Hellinger distance, and other mem-
bers of the Cressie-Read power-divergence family. The present paper indicates that
the Euclidean/Frobenius/Hilbert-Schmidt distance can be more powerful for gauging
the consistency of observed data with the assumption of homogeneity, too.
Keywords: chi-square, Fisher’s exact, Freeman-Tukey, likelihood ratio, power diver-
gence, root-mean-square
1 Introduction
The statistical analysis of categorical data is commonly formulated in the framework of
contingency-tables/cross-tabulations; Table 1 provides a typical two-way example (see, for
instance, Chapter 4 of Andersen, 1990, for a comprehensive treatment). A common task is to
ascertain whether the given data (displayed in Table 1) is consistent up to expected statistical
fluctuations with the model for homogeneity of proportions (displayed in Table 2). When
considering homogeneity, we assume that the probabilistic process generating the given data
fixes the column totals (but not the row totals) by construction. Therefore, to gauge whether
the given data displayed in Table 1 is consistent with the assumed homogeneity displayed in
Table 2, we do the following:
1. We generate s sets of draws, with the kth set consisting of n
,k independent and
identically distributed draws from the probability distribution (p1, p2, . . . , pr), where
p1 = n1,/n, p2 = n2,/n, . . . , pr = nr,/n. Note that pj = (nj, · n,k/n)/n,k for j = 1, 2,
. . . , r; these are homogeneous proportions (since p1, p2, . . . , pr are the same for every
column index k).
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Table 1: A typical two-way contingency-table/cross-tabulation (nj,k is a nonnegative integer
with j = 1, 2, . . . , r, k = 1, 2, . . . , s; nj, =
∑s
k=1 nj,k is a row total with j = 1, 2, . . . , r;
n
,k =
∑r
j=1 nj,k is a column total with k = 1, 2, . . . , s; and n, =
∑r
j=1
∑s
k=1 nj,k = n is the
grand total)
1 2 · · · s
1 n1,1 n1,2 · · · n1,s n1,
2 n2,1 n2,2 · · · n2,s n2,
...
...
...
. . .
...
...
r nr,1 nr,2 · · · nr,s nr,
n
,1 n,2 · · · n,s n,
Table 2: The model for homogeneity of proportions (n1,, n2,, . . . , nr, are the row totals;
n
,1, n,2, . . . , n,s are the column totals; and n, = n is the grand total)
1 2 · · · s
1 n1, · n,1/n n1, · n,2/n · · · n1, · n,s/n n1,
2 n2, · n,1/n n2, · n,2/n · · · n2, · n,s/n n2,
...
...
...
. . .
...
...
r nr, · n,1/n nr, · n,2/n · · · nr, · n,s/n nr,
n
,1 n,2 · · · n,s n,
2. For each of the s sets of draws — say the kth set — we define Nj,k to be the number
of draws falling in the jth row, for j = 1, 2, . . . , r.
3. We calculate the probability P that the discrepancy between the simulated counts Nj,k
and the model Nj, · N,k/n is greater than or equal to the discrepancy between the
observed counts nj,k and the assumed nj, · n,k/n. When calculating this probability,
we view Nj,k and Nj, as random, while viewing all other numbers as fixed. Please note
that, by construction, N
,k = n,k for k = 1, 2, . . . , s.
The number P defined in Step 3 is known as the (exact) P-value. Given the P-value
P , we can have 100(1 − P )% confidence that the observed draws are not consistent with
assuming the homogeneity displayed in Table 2. See Section 3 of Perkins et al. (2011) for
further discussion of P-values and their interpretation; Section 3 of Perkins et al. (2011)
details subtleties involved in the definition and interpretation of these P-values.
The definition above of the P-value P requires a metric for measuring the discrepancies.
The canonical choices are χ2 and the log–likelihood-ratio G2:
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χ2 =
r∑
j=1
s∑
k=1
(nj,k − (nj, · n,k/n))2
nj, · n,k/n (1)
X2 =
r∑
j=1
s∑
k=1
(Nj,k − (Nj, ·N,k/n))2
Nj, ·N,k/n (2)
Pχ2 = Prob{X2 ≥ χ2} (3)
g2 = 2
r∑
j=1
s∑
k=1
nj,k · ln
(
nj,k
nj, · n,k/n
)
(4)
G2 = 2
r∑
j=1
s∑
k=1
Nj,k · ln
(
Nj,k
Nj, ·N,k/n
)
(5)
Pg2 = Prob{G2 ≥ g2} (6)
Other possibilities include the Hellinger (or Freeman-Tukey) distance and the Frobenius (or
Hilbert-Schmidt or Euclidean) distance:
h2 = 4
r∑
j=1
s∑
k=1
(
√
nj,k −
√
nj, · n,k/n)2 (7)
H2 = 4
r∑
j=1
s∑
k=1
(
√
Nj,k −
√
Nj, ·N,k/n)2 (8)
Ph2 = Prob{H2 ≥ h2} (9)
f 2 =
r∑
j=1
s∑
k=1
(nj,k − (nj, · n,k/n))2 (10)
F 2 =
r∑
j=1
s∑
k=1
(Nj,k − (Nj, ·N,k/n))2 (11)
Pf2 = Prob{F 2 ≥ f 2} (12)
When taking probabilities in (3), (6), (9), and (12), we view the uppercase X2, G2, H2, and
F 2 as random variables, while viewing the lowercase χ2, g2, h2, and f 2 as fixed numbers.
As discussed, for example, by Rao (2002), X2, G2, and H2 all converge to the same
distribution in the limit of large numbers of draws — X2, G2, and H2 are the best-known
members of the Cressie-Read power-divergence family. F 2 is not a member of the Cressie-
Read power-divergence family and does not necessarily converge to the same distribution as
X2, G2, and H2. Perkins et al. (2011) illustrated the many advantages of F 2 when neither
the row totals nor the column totals are fixed; the present paper illustrates the advantages
when the column totals are fixed. However, F 2 is not uniformly more powerful than the
classical statistics. We recommend using both F 2 and a classical statistic such as G2.
In the sequel, Section 2 summarizes an algorithm for computing the P-values defined
above. Section 3 analyzes several data sets. Section 4 draws some conclusions.
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2 Computation of P-values
The definitions of the P-values in (3), (6), (9), and (12) involve the probabilities of certain
events. In the present paper, we compute these probabilities via Monte-Carlo simulations
with guaranteed error bounds. Specifically, we conduct a large number m of simulations; in
each simulation — say the ℓth — we perform the following steps (using the data of Table 1):
1. We generate s sets of draws, with the kth set consisting of n
,k independent and
identically distributed draws from the probability distribution (p1, p2, . . . , pr), where
p1 = n1,/n, p2 = n2,/n, . . . , pr = nr,/n. Note that pj = (nj, · n,k/n)/n,k for j = 1, 2,
. . . , r; these are homogeneous proportions (since p1, p2, . . . , pr are the same for ev-
ery column index k). Furthermore, the underlying distribution of the draws does not
depend on ℓ.
2. For each of the s sets of draws — say the kth set — we define n
(ℓ)
j,k to be the number
of draws falling in the jth row, for j = 1, 2, . . . , r.
3. We calculate the discrepancy f 2(ℓ) between the simulated counts n
(ℓ)
j,k and the model
n
(ℓ)
j, · n(ℓ),k/n, that is,
f 2(ℓ) =
r∑
j=1
s∑
k=1
(n
(ℓ)
j,k − (n(ℓ)j, · n(ℓ),k/n))2. (13)
An estimate of the P-value Pf2 is the fraction of f
2
(1), f
2
(2), . . . , f
2
(m) which are greater
than or equal to f 2 defined in (10). As discussed in Section 3 of Perkins et al. (2011), the
standard error of the estimate is
√
Pf2(1− Pf2)/m, where m is the number of simulations.
Needless to say, we can compute the P-values for χ2, g2, and h2 via similar procedures,
with the same error bounds.
Remark 2.1. For all computations reported in the present paper, we generated random
numbers via the C programming language procedure given on page 9 of Marsaglia (2003),
implementing the recommended complementary multiply with carry.
3 Data analysis
To compare the performance of the various metrics for measuring the discrepancies between
observed and simulated data, we analyze several data sets. Using the procedure of Sec-
tion 2, we conduct m = 4,000,000 Monte-Carlo simulations per P-value, for each of the
examples presented below. The standard error of the resulting estimate for the P-value P is
then
√
P (1− P )/2000; see Section 3 of Perkins et al. (2011). Before reporting the P-values
associated with the data sets, we make two remarks concerning their interpretation:
Remark 3.1. A significance test can only indicate that observed data cannot be reasonably
assumed to have arisen from the model of homogeneous proportions; a significance test
cannot prove that the observed data can be reasonably assumed to have arisen from the
model of homogeneity. Thus, aside from considerations of multiple testing, if any statistic
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strongly signals that the data cannot be reasonably assumed to have arisen from the model
of homogeneity, then we must reject (or at least question) the model — irrespective of any
large P-values for other statistics. For instance, if the P-value for the Frobenius distance f 2
is very small, then we should not accept the model of homogeneity, not even if the P-values
for χ2, the log–likelihood-ratio g2, and the Freeman-Tukey/Hellinger-distance h2 are large.
Remark 3.2. The term “negative log-likelihood” used in the present section refers to the
statistic that is simply the negative of the logarithm of the likelihood. The negative log-
likelihood is the same statistic used in the generalization of Fisher’s exact test discussed
by Guo and Thompson (1992); unlike the log–likelihood-ratio G2, this statistic involves only
one likelihood, not the ratio of two. We mention the negative log-likelihood just to facilitate
comparisons; we are not asserting that the likelihood on its own (rather than in a ratio) is
a good gauge of the relative sizes of deviations from a model.
The 11 × 2 Table 3 displays the data for our first example, which has 22 entries in all.
Table 4 displays the model of homogeneous proportions for Table 3. The P-values for Table 3
for the assumption that Table 4 gives the correct underlying distribution are
χ2 (X2): .0868
log–likelihood-ratio (G2): .0906
Freeman-Tukey/Hellinger (H2): .0959
negative log-likelihood: .0905
Frobenius (F 2): .00838
Please note that the P-value for the Frobenius distance is over an order of magnitude smaller
than the P-values for the classical statistics.
The 7 × 3 Table 7 displays the data for our second example, which has 21 entries in
all. Table 8 displays the model of homogeneous proportions for Table 7. The P-values for
Table 7 for the assumption that Table 8 gives the correct underlying distribution are
χ2 (X2): .145
log–likelihood-ratio (G2): .292
Freeman-Tukey/Hellinger (H2): .493
negative log-likelihood: .132
Frobenius (F 2): .0286
Please note that the P-value for the Frobenius distance is over four times smaller than the
P-values for the classical statistics.
The 9 × 2 Table 11 displays the data for our third example, which has 18 entries in all.
Table 12 displays the model of homogeneous proportions for Table 11. The P-values for
Table 11 for the assumption that Table 12 gives the correct underlying distribution are
χ2 (X2): .123
log–likelihood-ratio (G2): .138
Freeman-Tukey/Hellinger (H2): .157
negative log-likelihood: .114
Frobenius (F 2): .0344
Please note that the P-value for the Frobenius distance is over three times smaller than the
P-values for the classical statistics.
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The 5 × 3 Table 15 displays the data for our final example, which has 15 entries in all.
Table 16 displays the model of homogeneous proportions for Table 15. The P-values for
Table 15 for the assumption that Table 16 gives the correct underlying distribution are
χ2 (X2): .276
log–likelihood-ratio (G2): .171
Freeman-Tukey/Hellinger (H2): .0794
negative log-likelihood: .235
Frobenius (F 2): .199
In this example, none of the statistics produces a very small P-value; the smallest arises from
the Freeman-Tukey/Hellinger distance in this case.
Remark 3.3. Appropriate binning (or rebinning) to uniformize the frequencies associated
with the entries in the contingency-tables/cross-tabulations can mitigate the problem with
the classical statistics. Yet rebinning is a black art that is liable to improperly influence the
result of a significance test, and the usual data-dependent rebinning calls for Monte-Carlo
simulations to calculate P-values accurately anyways. Rebinning always requires careful
extra work. A principal advantage of the Frobenius distance is that it does not require any
rebinning; indeed, the Frobenius distance is most powerful without any rebinning. Note also
that optimally rebinning data such as that displayed in Table 3 can be very challenging.
4 Conclusion
The Frobenius distance is significantly more powerful than the classical statistics for gauging
the consistency of observed data with the assumption of homogeneity in many of the examples
of the present paper. This may or may not be typical of most applications; actually, we
suspect that our last example — in which all the statistics perform similarly — is the most
representative. Even so, both the present paper and the applications of Perkins et al. (2011)
illustrate that there are many important circumstances in which the Frobenius distance is
much more powerful than the classical statistics.
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Table 3: Results of polls in June 1983 for Danish parliamentary elections, from Chapter 4
of Andersen (1990)
Party Poll 1 Poll 2
A 416 (33.1%) 268 (38.9%)
B 45 (3.6%) 22 (3.2%)
C 338 (26.9%) 160 (23.2%)
E 13 (1.0%) 6 (0.9%)
F 131 (10.4%) 66 (9.6%)
K 18 (1.4%) 10 (1.5%)
M 47 (3.7%) 16 (2.3%)
Q 20 (1.6%) 8 (1.2%)
V 129 (10.3%) 92 (13.4%)
Y 22 (1.8%) 9 (1.3%)
Z 76 (6.1%) 32 (4.6%)
All 1255 (100.0%) 689 (100.0%)
Table 4: The model of homogeneous proportions for Table 3
Party Poll 1 Poll 2
A 441.6 (35.2%) 242.4 (35.2%)
B 43.3 (3.4%) 23.7 (3.4%)
C 321.5 (25.6%) 176.5 (25.6%)
E 12.3 (1.0%) 6.7 (1.0%)
F 127.2 (10.1%) 69.8 (10.1%)
K 18.1 (1.4%) 9.9 (1.4%)
M 40.7 (3.2%) 22.3 (3.2%)
Q 18.1 (1.4%) 9.9 (1.4%)
V 142.7 (11.4%) 78.3 (11.4%)
Y 20.0 (1.6%) 11.0 (1.6%)
Z 69.7 (5.6%) 38.3 (5.6%)
All 1255.0 (100.0%) 689.0 (100.0%)
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Table 5: Differences between the entries of Table 3 and the corresponding entries of Table 4
Party Poll 1 Poll 2
A −25.6 25.6
B 1.7 −1.7
C 16.5 −16.5
E 0.7 −0.7
F 3.8 −3.8
K −0.1 0.1
M 6.3 −6.3
Q 1.9 −1.9
V −13.7 13.7
Y 2.0 −2.0
Z 6.3 −6.3
All 0.0 0.0
Table 6: The entries of Table 5 divided by the square roots of the corresponding entries of
Table 4
Party Poll 1 Poll 2
A −1.2 1.6
B 0.3 −0.4
C 0.9 −1.2
E 0.2 −0.3
F 0.3 −0.5
K −0.0 0.0
M 1.0 −1.3
Q 0.5 −0.6
V −1.1 1.5
Y 0.4 −0.6
Z 0.8 −1.0
All 0.0 0.0
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Table 7: Reasons for (or absence of) premature termination of the treatment of maniacal
patients in three groups from Bowden et al. (1994) (the three groups are those treated with
divalproex, those treated with lithium, and those “treated” with a placebo)
Reason Divalproex Lithium Placebo
Lack of efficacy 21 (30.4%) 12 (33.3%) 38 (51.4%)
Intolerance 4 (5.8%) 4 (11.1%) 2 (2.7%)
Recovered 3 (4.3%) 2 (5.6%) 2 (2.7%)
Noncompliance 1 (1.4%) 1 (2.8%) 3 (4.1%)
Another illness 0 (0.0%) 1 (2.8%) 0 (0.0%)
Administration 4 (5.8%) 2 (5.6%) 2 (2.7%)
Not terminated 36 (52.2%) 14 (38.9%) 27 (36.5%)
All 69 (100.0%) 36 (100.0%) 74 (100.0%)
Table 8: The model of homogeneous proportions for Table 7
Reason Divalproex Lithium Placebo
Lack of efficacy 27.4 (39.7%) 14.3 (39.7%) 29.4 (39.7%)
Intolerance 3.9 (5.6%) 2.0 (5.6%) 4.1 (5.6%)
Recovered 2.7 (3.9%) 1.4 (3.9%) 2.9 (3.9%)
Noncompliance 1.9 (2.8%) 1.0 (2.8%) 2.1 (2.8%)
Another illness 0.4 (0.6%) 0.2 (0.6%) 0.4 (0.6%)
Administration 3.1 (4.5%) 1.6 (4.5%) 3.3 (4.5%)
Not terminated 29.7 (43.0%) 15.5 (43.0%) 31.8 (43.0%)
All 69.0 (100.0%) 36.0 (100.0%) 74.0 (100.0%)
Table 9: Differences between the entries of Table 7 and the corresponding entries of Table 8
Reason Divalproex Lithium Placebo
Lack of efficacy −6.4 −2.3 8.6
Intolerance 0.1 2.0 −2.1
Recovered 0.3 0.6 −0.9
Noncompliance −0.9 0.0 0.9
Another illness −0.4 0.8 −0.4
Administration 0.9 0.4 −1.3
Not terminated 6.3 −1.5 −4.8
All 0.0 0.0 0.0
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Table 10: The entries of Table 9 divided by the square roots of the corresponding entries of
Table 8
Reason Divalproex Lithium Placebo
Lack of efficacy −1.2 −0.6 1.6
Intolerance 0.1 1.4 −1.0
Recovered 0.2 0.5 −0.5
Noncompliance −0.7 0.0 0.6
Another illness −0.6 1.8 −0.6
Administration 0.5 0.3 −0.7
Not terminated 1.2 −0.4 −0.9
All 0.0 0.0 0.0
Table 11: Results for the 2012 Republican U.S. presidential nomination, from a CBS News
poll of November 6–10, 2011 (released November 11, 2011) and from a Pew Research Center
poll of November 9–11, 2011 (released November 17, 2011), as reconstructed from percentages
rounded to the nearest whole numbers (the original counts were not reported) for Republican
primary voters
Candidate CBS Pew
Michele Bachmann 15 (4.6%) 21 (5.1%)
Herman Cain 69 (21.2%) 103 (25.0%)
Newt Gingrich 57 (17.5%) 66 (16.0%)
Jon Huntsman 4 (1.2%) 4 (1.0%)
Ron Paul 19 (5.8%) 33 (8.0%)
Rick Perry 31 (9.5%) 37 (9.0%)
Mitt Romney 57 (17.5%) 91 (22.1%)
Rick Santorum 8 (2.5%) 8 (1.9%)
Do not know 65 (20.0%) 49 (11.9%)
All 325 (100.0%) 412 (100.0%)
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Table 12: The model of homogeneous proportions for Table 11
Candidate CBS Pew
Michele Bachmann 15.9 (4.9%) 20.1 (4.9%)
Herman Cain 75.8 (23.3%) 96.2 (23.3%)
Newt Gingrich 54.2 (16.7%) 68.8 (16.7%)
Jon Huntsman 3.5 (1.1%) 4.5 (1.1%)
Ron Paul 22.9 (7.1%) 29.1 (7.1%)
Rick Perry 30.0 (9.2%) 38.0 (9.2%)
Mitt Romney 65.3 (20.1%) 82.7 (20.1%)
Rick Santorum 7.1 (2.2%) 8.9 (2.2%)
Do not know 50.3 (15.5%) 63.7 (15.5%)
All 325.0 (100.0%) 412.0 (100.0%)
Table 13: Differences between the entries of Table 11 and the corresponding entries of
Table 12
Candidate CBS Pew
Michele Bachmann −0.9 0.9
Herman Cain −6.8 6.8
Newt Gingrich 2.8 −2.8
Jon Huntsman 0.5 −0.5
Ron Paul −3.9 3.9
Rick Perry 1.0 −1.0
Mitt Romney −8.3 8.3
Rick Santorum 0.9 −0.9
Do not know 14.7 −14.7
All 0.0 0.0
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Table 14: The entries of Table 13 divided by the square roots of the corresponding entries
of Table 12
Candidate CBS Pew
Michele Bachmann −0.2 0.2
Herman Cain −0.8 0.7
Newt Gingrich 0.4 −0.3
Jon Huntsman 0.3 −0.2
Ron Paul −0.8 0.7
Rick Perry 0.2 −0.2
Mitt Romney −1.0 0.9
Rick Santorum 0.4 −0.3
Do not know 2.1 −1.8
All 0.0 0.0
Table 15: Reactions to prior treatment with lithium (when treated before with lithium) of
maniacal patients in three groups from Bowden et al. (1994) (the three groups are those
treated with divalproex, those treated with lithium, and those “treated” with a placebo)
Reaction Divalproex Lithium Placebo
Effective and
tolerated
22 (31.9%) 16 (44.4%) 19 (25.7%)
Effective but
not tolerated
7 (10.1%) 0 (0.0%) 6 (8.1%)
Ineffective but
tolerated
19 (27.5%) 11 (30.6%) 31 (41.9%)
Ineffective and
not tolerated
6 (8.7%) 4 (11.1%) 5 (6.8%)
No prior lithium
treatment
15 (21.7%) 5 (13.9%) 13 (17.6%)
All 69 (100.0%) 36 (100.0%) 74 (100.0%)
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Table 16: The model of homogeneous proportions for Table 15
Reaction Divalproex Lithium Placebo
Effective and
tolerated
22.0 (31.8%) 11.5 (31.8%) 23.6 (31.8%)
Effective but
not tolerated
5.0 (7.3%) 2.6 (7.3%) 5.4 (7.3%)
Ineffective but
tolerated
23.5 (34.1%) 12.3 (34.1%) 25.2 (34.1%)
Ineffective and
not tolerated
5.8 (8.4%) 3.0 (8.4%) 6.2 (8.4%)
No prior lithium
treatment
12.7 (18.4%) 6.6 (18.4%) 13.6 (18.4%)
All 69.0 (100.0%) 36.0 (100.0%) 74.0 (100.0%)
Table 17: Differences between the entries of Table 15 and the corresponding entries of
Table 16
Reaction Divalproex Lithium Placebo
Effective and tolerated 0.0 4.5 −4.6
Effective but not tolerated 2.0 −2.6 0.6
Ineffective but tolerated −4.5 −1.3 5.8
Ineffective and not tolerated 0.2 1.0 −1.2
No prior lithium treatment 2.3 −1.6 −0.6
All 0.0 0.0 0.0
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Table 18: The entries of Table 17 divided by the square roots of the corresponding entries
of Table 16
Reaction Divalproex Lithium Placebo
Effective and tolerated 0.0 1.3 −0.9
Effective but not tolerated 0.9 −1.6 0.3
Ineffective but tolerated −0.9 −0.4 1.2
Ineffective and not tolerated 0.1 0.6 −0.5
No prior lithium treatment 0.6 −0.6 −0.2
All 0.0 0.0 0.0
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